Azar Alex M II sold $11K of GH
Azar Alex M II sold 69 shares of Guardant Health, Inc. (GH) at $159.89 on 2026-10-14 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly under a pre-arranged 10b5-1 plan and the proceeds are modest, the information is mainly sentiment-oriented and not a direct fundamental catalyst.
Market read
Traders may note the insider sale, but the disclosed size and 10b5-1 structure suggest limited trading impact.
What to watch
The article provides no change in business outlook, guidance, or operating metrics, so traders should avoid extrapolating fundamentals from a single small sale.
Background
The article is an SEC Form 4 insider transaction disclosure for Guardant Health, Inc., reported by a director.
Ticker impact
Guardant Health director Azar Alex M II sold 69 shares at $159.89 under a pre-arranged 10b5-1 plan, totaling $11,032.41.
Likely limited impact, with any reaction confined to marginal sentiment rather than fundamentals.
The filing is a Form 4 insider transaction, explicitly tied to a Rule 10b5-1 plan, and the disclosed proceeds are small relative to typical market-moving thresholds.
Market effects
Minimal, as the disclosure is a small, routine insider sale rather than a sector-wide signal.
None expected.
None expected.
Counterpoint
Even with 10b5-1, repeated insider selling can sometimes coincide with broader risk management or diversification, which could matter if paired with other negative signals not present here.
Key entities
- issuerGuardant Health, Inc.
Public company whose director executed a small open-market sale under a Rule 10b5-1 plan.
- insiderAzar Alex M II
Director who sold 69 shares at $159.8900 on 2026-10-14.
